Peripheral artery disease (PAD) and chronic venous insufficiency (CVI) both affect your blood vessels and prevent your body from getting the oxygen-rich blood that it needs. The difference between the ...

In early January of 2024, the biotechnology research company Qvin™ made history; the FDA clearance of its Q-Pad™ and A1c Test marked the first FDA approval for menstrual blood health testing.

Every month, more than two billion people all around the world menstruate, generating a treasure trove of data that could indicate their health status. Yet, the sample containing this ...

Scientists are developing a new device that fits inside a menstrual pad and checks for "biomarkers" of disease in period blood. When you purchase through links on our site, we may earn an affiliate ...

Researchers developed a wearable pad that detects inflammation and cancer biomarkers in menstrual blood using smartphone analysis, enabling low-cost, non-invasive health monitoring at home. (Nanowerk ...

Peripheral artery disease (PAD) is a type of peripheral vascular disease (PVD). PVD involves various blood vessels outside the brain and heart. PAD refers to narrowed or blocked blood vessels that ...

Credit: Qvin. The kit is intended for the collection of menstrual blood samples by individuals 18 years of age and older using the Q-Pad. The Food and Drug Administration (FDA) has cleared Qvin’s ...

Peripheral artery disease and venous insufficiency share many symptoms but affect different types of blood vessels. Each has distinguishing symptoms, risk factors, and diagnostic markers. Peripheral ...